Trade Setup Buy Target – $39.62 Sell Target – $46.81 Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing drugs to treat central nervous system (CNS) diseases and other disorders in the United States. Its lead product candidate, d-Methadone, is being developed as a rapidly acting, oral agent for the treatment of depression, neuropathic […]
Read MorePlus, President Trump issued an executive order banning TikTok and WeChat, July job gains came in just under 1.8 million, and coronavirus relief bill talks have stalled.
Read MoreBuy Price: $2.00 or better Sell Price: TradersPro Sell Signal CohBar, Inc., a clinical stage biotechnology company, engages in the research and development of mitochondria based therapeutics (MBTs) for the treatment of diseases associated with aging and metabolic dysfunction. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, type 2 diabetes […]
Read MorePlus, weekly jobless claims hit their lowest level in the pandemic era but still came in above 1 million, White House and congressional Democratic negotiators have a self-imposed deadline of Friday to come to agreement on a relief package, and Bausch Health is spinning off is eye care business.
Read MorePlus, White House and Democratic negotiators made progress toward a deal on a new relief bill, ADP reported a sharp decrease in job creation in July, and Square’s earnings release was leaked ahead of schedule.
Read MoreTrade Setup Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day. The stocks are pausing a trend either up or down, with a new bar over the prior day open or close. These are high reward to risk stocks with the […]
Read MoreTrade Setup Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day. The stocks are pausing a trend either up or down, with a new bar over the prior day open or close. These are high reward to risk stocks with the […]
Read MoreOne analyst says this stock could gain nearly 30% in the near-term.
Read MorePlus, Republicans are expected to release the details of their coronavirus relief bill today, Hasbro shares are down after a 29% drop in revenue in the second quarter, and Target will be closed on Thanksgiving.
Read MoreThese 3 stocks could be the best bets in the race to develop a vaccine for COVID-19.
Read MorePlus, the U.S. ordered China to close its consulate in Houston, Nike announced a leadership shake-up, Slack filed a complaint against Microsoft with the European Commission, and United Airlines reported earnings.
Read MorePlus, it’s looking unlikely Congress will pass another coronavirus relief bill before the end of July, IBM reported an earnings beat, eBay sold its classified ads unit, and Men’s Wearhouse-parent Tailored Brands is laying off 20% of its workforce and considering closing up to 500 stores.
Read MorePlus, AstraZeneca said its coronavirus vaccine developed with Oxford University showed a promising immune response in an early study, airline stocks are down after TSA said air travel is down for the first time since April, and Amazon is up after two bullish upgrades.
Read MoreBuy Price: $22.00 or better Sell Price: TradersPro Sell Signal Alpha Pro Tech, Ltd., together with its subsidiaries, engages in developing, manufacturing, and marketing a line of disposable protective apparel and infection control, and building supply products in the United States and internationally. The company operates through two segments, Building Supply and Disposable Protective Apparel. […]
Read MorePlus, jobless claims came in higher than 1 million for the seventeenth week in a row, security experts warned Russian hackers are trying to steal COVID-19 vaccine research, Morgan Stanley reported better-than-expected earnings, and Tesla shares are down after a report that its vehicle registrations were down by nearly half in the second quarter.
Read More